In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Target Corp.

Imagining A US Where ‘Clean At Sephora’ Is De Facto Law

NGO-backed legislation at US federal, state and local levels to ban cosmetic ingredients and contain contaminant levels would be largely gratuitous if all cosmetics brands were compelled to be “Clean at Sephora.” For now, companies’ adherence to Sephora’s and peers’ green/clean chemistry principles remains voluntary, but retailers’ role as surrogate regulators seems only to be gaining in strength. 
Beauty Retail

Infant Formula Woes Turn Perrigo's Q2 Sour Despite Solid Americas’ OTC Sales

Perrigo reports 4% Q2 sales growth for OTC drugs in the Americas region was offset by nearly 15% drop in infant formula sale. Total consumer sales in the Americas slipped 2.5% to $582m, but CEO Murray Kessler says brighter days are ahead on benefits from Ranir oral care acquisition.

Sales & Earnings OTC Drugs

Top Retailers Driving Chemical Policy Adherence With ‘Clean Beauty’ Seals

What exactly is “clean beauty”? At Target and Sephora, it means phasing out many traditional preservatives, among other commonly used but “unwanted” ingredients, and getting prominent placement and the retailers’ “Clean” stamps of approval in return.

Beauty Retail

US FDA Regulatory Roundup: Ceba-Tek GMP Warning, Altaire Expands Recall

GMP violations FDA warned Ceba-Tek about following an inspection in January and February include problems agency officials also noted in 2014 and 2015; Altaire Pharmaceuticals recalls of ophthalmic products due to lack of sterility assurance passes 500 lots, including 28 of Clear Eyes announced July 16.
Dietary Supplements OTC Drugs
See All

Company Information

  • Industry
  • Distributors
  • Miscellaneous
  • Pharmaceuticals
    • OTC, Consumer
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Target Corp.
  • Senior Management
  • Brian Cornell, Chmn. & CEO
    John J Mulligan, EVP & CFO
  • Contact Info
  • Target Corp.
    Phone: (612) 304-6073
    1000 Nicollet Mall
    Minneapolis, MN 55403
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register